is contrave glp 1 CONTRAVE- For Patients and Caregivers Contrave vs. Wegovy for Weight

The cardiovascular indication for Wegovy, FDA-approved in March 2024 after the SELECT trial (Lincoff et al

While cost is currently a barrier to uptake, growing competition and the arrival of generic and oral formulations are expected to lower costs significantly

And the frustration runs deep, because when everyone around you talks about how these medications changed their life, being the person it did not work for feels isolating

Addressing nutritional needs, side effects, exercise integration, and wellness-focused experiences allows companies to resonate authentically with GLP-1 users while navigating new cultural and social dynamics